LOGUERCIO, Carmelina
 Distribuzione geografica
Continente #
EU - Europa 5.234
NA - Nord America 5.076
AS - Asia 567
SA - Sud America 36
OC - Oceania 8
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.929
Nazione #
US - Stati Uniti d'America 5.047
IE - Irlanda 1.660
UA - Ucraina 967
GB - Regno Unito 710
IT - Italia 572
DE - Germania 407
SE - Svezia 274
CN - Cina 260
FI - Finlandia 243
TR - Turchia 188
GR - Grecia 160
FR - Francia 154
VN - Vietnam 53
KR - Corea 23
BR - Brasile 22
BE - Belgio 18
NL - Olanda 16
IN - India 15
MX - Messico 14
RU - Federazione Russa 13
ES - Italia 11
CA - Canada 9
AU - Australia 8
CL - Cile 5
IR - Iran 5
JP - Giappone 5
MK - Macedonia 5
PK - Pakistan 5
PL - Polonia 5
AT - Austria 4
DO - Repubblica Dominicana 4
ID - Indonesia 4
AR - Argentina 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
HK - Hong Kong 3
RO - Romania 3
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
NO - Norvegia 2
SG - Singapore 2
TW - Taiwan 2
BF - Burkina Faso 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
JM - Giamaica 1
KE - Kenya 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
Totale 10.929
Città #
Dublin 1.657
Jacksonville 1.453
Chandler 927
Princeton 275
Medford 228
Roxbury 149
Boardman 145
San Mateo 132
Ann Arbor 128
Wilmington 118
Beijing 101
Woodbridge 87
New York 70
Cambridge 61
Caserta 57
Des Moines 54
Dong Ket 52
Bremen 47
Nanjing 43
Ashburn 37
Naples 32
Düsseldorf 30
Jinan 24
Mountain View 21
Norwalk 20
Brussels 18
Houston 17
Napoli 16
Boydton 15
Auburn Hills 14
Kunming 13
Redwood City 13
Venice 13
Rome 11
Jinju 10
Shenyang 10
Lanzhou 9
Atella 8
Catania 8
Milan 8
Paris 8
Potenza 8
Groningen 7
Los Angeles 7
Nanchang 7
Tianjin 7
Changsha 6
Fairfield 6
Helsinki 6
Madrid 6
Sennori 6
Zhengzhou 6
Bovisio 5
Daejeon 5
Hanover 5
Lissone 5
Orange 5
Portici 5
Salerno 5
San Mango 5
Santiago 5
Berlin 4
Bologna 4
Dallas 4
Falls Church 4
Gyeonggi-do 4
Hangzhou 4
Hebei 4
Moscow 4
Santo Domingo 4
Torino 4
Torre Del Greco 4
Vienna 4
Amsterdam 3
Aversa 3
Bari 3
Bisaccia 3
Brescia 3
Brno 3
Celâl 3
Dearborn 3
Dzierzoniow 3
Genoa 3
Haikou 3
Jiaxing 3
Lodi 3
Manaus 3
Marano Di Napoli 3
New Delhi 3
Nocera Superiore 3
Ottawa 3
Palermo 3
Pavia 3
Pine Grove 3
Quito 3
Segrate 3
Shanghai 3
Taizhou 3
Trieste 3
Acerra 2
Totale 6.384
Nome #
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 103
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 102
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 100
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 99
Intrafamilial spread of Helicobacter pylori infection 88
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 84
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 79
Gut-Brain Axis: a new revolution to understand the pathogenesis of autism and other severe neurological diseases 73
Chronic inflammation and oxidative stress in human carcinogenesis 70
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 70
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 70
Studio nutrizionale del cirrotico. Confronto fra plicometria cutanea ed acqua corporea 67
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 67
NUTRITIONAL STATUS IN LIVER CIRRHOSIS 65
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 64
A case of hepatotoxicity caused by green tea 64
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 64
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 63
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 62
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 62
L'uomo e il vino 61
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 61
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 60
Alterazione della sensibilità gustativa nel diabete mellito 60
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 60
Crohn’s disease and skin 59
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 59
Trace elements and chronic liver diseases 58
Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease 58
Alter Ego: Sindrome metabolica e fegato 56
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 56
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 56
AISF position paper on liver disease and pregnancy 55
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 55
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 55
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 54
Age affects glutathione content and glutathione-transferase activity in human gastric mucosa 54
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 54
Fegato e glutatione 54
Epidemiologia delle epatiti croniche ad eziologia virale. 54
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 53
Management of chronic liver disease by general practitioners in southern Italy: unmet educational needs 52
Treatment of chronic hepatic encephalopathy with rifaximin. In: Encefalopatia epatica 52
Fegato e alcol: un connubio difficile 52
Una spia sulla tavola dei nostri ragazzi 52
Alcoholic liver disease and hepatitis C chronic infection 51
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 51
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 50
Secrezione salivare e tests strumentali di neuropatia diabetica autonoma 50
Effect of gastrin upon salivary flow rate in normal subject, duodenal ulcer and cirrhotic patients. 50
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 50
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 50
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 50
About gut microbiota: Why? 49
Effetti metabolici della silibina: studi in vitro e in vivo. 49
Gut microbiota and the liver 49
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 48
Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study 47
Liver p53 expression in patients with HCV-related chronic hepatitis 47
alcoholic liver cirrhosis after the advent of hepatits C virus: some reflections on its epidemiology and on the concept of attributable risk 47
Sensibilita' gustativa e patologia cronica del fegato 47
L'alimentazione nel soggetto con epatite virale acuta e cronica 47
Interfences of a symbiotic formulation (FB, Flortec®, Bracco s.p.a., Italy) on a gastric and intestinal permeability in rats with experimentally induced chronic liver damage. 47
Permeabilità intestinale e malattie epatiche. 47
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 47
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 47
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 47
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. 46
Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives 46
Clinical nutrition practice in Italian Gastroenterology Units 46
Factors associated with poor health-related quality of life of patients with cirrhosis 46
Iperbilirubinemia da acido nicotinico: potenziamento da contemporaneo carico di BSF. 46
Il consumo alcolico nella regione Campania: quali le nuove realtà 46
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 46
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 46
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 46
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 46
TPN-related digestive alterations. Animal and human data in the non-critical setting 45
Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting 45
[Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion] 45
TPN-related digestive complications in critically ill patients 45
Oxidative stress in viral and alcoholic hepatitis 45
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system] 45
Inhibitory effect of caerulein on salivary secretion in man 45
Antioxidants in the treatment and prevention of gastric mucosal damage 45
Asse intestino-fegato: ruolo della flora batterica e dei probiotici. 45
PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy 45
Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies 44
Focal gastric blood perfusion in relation with the endoscopic signs and liver function in cirrhotic patients 44
The role of foods as addictive or protective factors in alcohol-induced chronic liver disease 44
age aggects glutathione content and glutathione- transferease activity in human gasstric mucosa 44
Aspetti alimentari, stato nutrizionale e malattie dell’apparato digerente – Interazione nell’età evolutiva e nell’adulto 44
Il nostro fegato è sempre più grasso 44
Epidemiology and natural history of alcoholic liver disease 44
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 44
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 43
Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats 43
Influenza di sesso ed età sulla sensibilita' gustativa in soggetti sani 43
Alcool e mucosa gastrica: ruolo dei composti sulfidrilici 43
The influence of interoceptive awareness on functional connectivity in patients with irritable bowel syndrome 43
Totale 5.460
Categoria #
all - tutte 41.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 24 15
2019/20201.448 274 271 16 22 249 22 274 67 123 59 57 14
2020/20212.073 223 10 259 85 298 27 288 241 16 285 229 112
2021/20221.589 142 4 11 48 589 19 31 35 57 52 148 453
2022/20233.277 319 87 34 306 314 262 4 216 1.601 29 53 52
2023/2024966 119 45 64 126 438 82 45 24 1 19 3 0
Totale 11.209